Skip to main content

BANK OF AMERICA CORP /DE/

Bank

Position in RCUS — Arcus Biosciences, Inc.

CIK 70858 CHARLOTTE, NC

Position in RCUS

as of Mar 31, 2026 · filed May 18, 2026
Position Value
$13,955,067
-$9,894,423 QoQ
Shares Held
646,068
-35.4% QoQ
Ownership
0.514%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 87.8608753258171.ToString("F0")% Shared 0.ToString("F0")% None 12.139124674182904.ToString("F0")%

Common Shares in RCUS Over Time

Shares Held

Position Value (USD)

Derivatives in RCUS

reported options exposure · as of Mar 31, 2024
CallValue
$0
CallShares
0
PutValue
$37,760
PutShares
2,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

BANK OF AMERICA CORP /DE/ holds $8,548,405,235 across 346 Biotechnology names. RCUS ranks #89 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RCUS

Export CSV
28 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $13,955,067 646,068
2025-12-31 $23,849,490 1,000,818
2025-09-30 $18,506,620 1,360,781
2025-06-30 $4,050,617 497,619
2025-03-31 $1,974,831 251,571
2024-12-31 $2,384,557 160,145
2024-09-30 $2,154,558 140,913
2024-06-30 $2,155,378 141,522
2024-03-31 $37,760 2,000
2024-03-31 $2,823,539 149,552
2023-12-31 $3,149,435 164,892
2023-12-31 $38,200 2,000
2023-09-30 $3,460,955 192,811
2023-09-30 $35,900 2,000
2023-06-30 $3,818,704 188,021
2023-03-31 $20,961,734 1,149,218
2022-12-31 $2,874,746 139,011
2022-09-30 $3,910,316 149,477
2022-06-30 $2,077,574 81,988
2022-03-31 $4,338,268 137,461
2021-12-31 $3,944,690 97,472
2021-09-30 $2,394,521 68,670
2021-06-30 $1,010,170 36,787
2021-03-31 $899,036 32,017
2020-12-31 $944,864 36,397
2020-09-30 $505,937 29,518
2020-06-30 $914,017 36,945
2020-03-31 $288,022 20,751